1 completed, 1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Antiviral Drugs: new trials by email Literature Review of Antiviral Drugs trials Research Report on Antiviral Drugs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Dengue Antiviral Platform Trial Molnupiravir 400 mg, VIS513 (a monoclonal antibody), Remdesivir 100mg - Dengue, Antiviral Drugs | Phase 2 | Recruiting | Oxford University Clinical Research Unit, Vietnam | 500 | 2026-04-20 | 2026-09-28 |
| The Renal Safety of Tenofovir Alafenamide in HBV-related Acute-on-chronic Liver Failure: Real-World Study tenofovir alafenamide, Entecavir - Antiviral Drugs | Not applicable | Completed | Xiangya Hospital of Central South University | 272 | 2022-05-01 | 2022-07-12 |
| A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports Implantation of veinous access ports - Veinous, Chemotherapy | Unknown | Perouse Medical | 250 | 2022-03-15 | 2022-08-29 |
Dengue (1) · Hyperphagia (1)
Arbovirus Infections (1) · Flaviviridae Infections (1) · Flavivirus Infections (1) · Hemorrhagic Fevers, Viral (1) · Infections (1) · Mosquito-Borne Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · RNA Virus Infections (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Vector Borne Diseases (1) · Virus Diseases (1)
Infusions, Intravenous (1) · entecavir (1) · molnupiravir (1) · remdesivir (1) · tenofovir alafenamide (1)
Oxford University Clinical Research Unit, Vietnam (1) · Perouse Medical (1) · Xiangya Hospital of Central South University (1)
China (1) · France (1) · Malaysia (1) · Vietnam (1)